economist semaglutide Until recently, GLP-1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. For poorer countries, wider access to these medicines could transform the treatment of chronic illnesses. That The Economist article on Mounjaro

When a B12 injection is administered to you, you can expect the following main benefit: Restoration of vitamin B12 in the cells, which leads to acceleration of B12 levels for circulation in critical organs

Omada is bullish on policy tailwinds to drive tech-enabled chronic condition management such as the Prevent Diabetes Act, which cemented Medicare coverage for virtual diabetes prevention programs, and the CMS ACCESS model

Knowing the safety issues with injectable B12 helps us use it safely

Big Pharma expands its portfolio Earlier this month, Eli Lilly announced detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity, or overweight with a weight-related medical problem and without diabetes